In this interview, Prof. Stride describes the potential of engineered bubbles as a tool for improving cancer drug delivery. Benefits include a greater amount of drugs delivered to a tumor and reduced amounts of drugs delivered to healthy cells. As a result, treatment becomes more effective with fewer side effects experienced.
Women to Watch: Engineered bubbles as a drug delivery tool with Eleanor Stride
An interview with Professor Eleanor Stride published on the Oncology Central website.
Professor Stride discusses the the application of engineered bubbles in oncology. She is working to understand if engineered bubbles can induce an immune response that causes tumors to shrink. Bubbles in combination with ultrasound can be useful for delivering drugs to tumors that have a poor blood supply. Prof Stride's current work focuses on understanding the mechanisms that allow the bubbles to work for cancer treatment.
Why is this important?
Drawing on the body's own immune system and improving the cancer drug delivery pathways can help us improve the effectiveness of cancer treatments and reduce side effects.
The interview
Researcher Spotlight: Prof. Jennifer Rohn
Researcher Spotlight